Interim analysis from a prospective multicenter study of next-generation sequencing minimal residual disease assessment and CT monitoring for surveillance after frontline treatment in diffuse large B-cell lymphoma Meeting Abstract
| Authors: | Kumar, A.; Westin, J.; Schuster, S. J.; Nowakowski, G. S.; Lossos, I. S.; Batlevi, C. L.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Jacob, A. P.; Joffe, E.; Joseph, A.; von Keudell, G. R.; Laraque, L.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Mullins, C. D.; Noy, A.; Owens, C.; Palomba, M. L.; Portlock, C. S.; Rodriguez-Rivera, I.; Salles, G.; Seshan, V.; Straus, D. J.; Vemuri, S.; Younes, A.; Zelenetz, A. D. |
| Abstract Title: | Interim analysis from a prospective multicenter study of next-generation sequencing minimal residual disease assessment and CT monitoring for surveillance after frontline treatment in diffuse large B-cell lymphoma |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205606071 |
| DOI: | 10.1182/blood-2020-138889 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 46 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
